Highly active antiretroviral therapy and coronary heart disease: the need for perspective

被引:20
作者
Egger, M
Junghans, C
Friis-Moller, N
Lundgren, JD
机构
[1] Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England
[2] Hvidovre Univ Hosp, Dept Infect Dis, Copenhagen, Denmark
关键词
anti-HIV agents; lipodystrophy; insulin resistance; hyperlipidaemia; coronary disease; prospective studies;
D O I
10.1097/00002030-200100005-00023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:S193 / S201
页数:9
相关论文
共 68 条
[1]   CARDIOVASCULAR-DISEASE RISK PROFILES [J].
ANDERSON, KM ;
ODELL, PM ;
WILSON, PWF ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1991, 121 (01) :293-298
[2]   AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].
ANDERSON, KM ;
WILSON, PWF ;
ODELL, PM ;
KANNEL, WB .
CIRCULATION, 1991, 83 (01) :356-362
[3]  
[Anonymous], 1984, J Epidemiol Community Health, V38, P259
[4]  
[Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1
[5]  
[Anonymous], 1989, WORLD HLTH STAT ANN, P27
[6]   Do triglycerides provide meaningful information about heart disease risk? [J].
Avins, AL ;
Neuhaus, JM .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (13) :1937-1944
[7]   Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors [J].
Behrens, G ;
Dejam, A ;
Schmidt, H ;
Balks, HJ ;
Brabant, G ;
Körner, T ;
Stoll, M ;
Schmidt, RE .
AIDS, 1999, 13 (10) :F63-F70
[8]  
BHIVA Writing Committee, 2000, HIV Med, V1, P76
[9]   Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].
Carpenter, CCJ ;
Cooper, DA ;
Fischl, MA ;
Gatell, JM ;
Gazzard, BG ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schechter, M ;
Schooley, RT ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390
[10]   Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].
Carr, A ;
Samaras, K ;
Thorisdottir, A ;
Kaufmann, GR ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1999, 353 (9170) :2093-2099